search
Back to results

BC-DAISY: A Breast Cancer Decision Aid System

Primary Purpose

Breast Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TX-plore
Sponsored by
Rhode Island Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Breast Cancer focused on measuring decision aids, high risk, breast cancer, breast cancer prevention

Eligibility Criteria

21 Years - 75 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: between the ages of 21 - 75 at least one first degree relative with breast cancer or a Gail Model score signifying high risk female having had contact with a PCP (physician or nurse practitioner)within the last year being a patient at a participating clinic (for usability and pilot study) Exclusion Criteria: Inability to give informed, voluntary consent History of breast cancer or LCIS Language, vision, or reading difficulties, or non-English speaking Pregnancy women over 75 because of the lack of data guiding the impact of preventive treatments among this age group.

Sites / Locations

  • Rhode Island Hospital

Outcomes

Primary Outcome Measures

Usability feedback on new decision aid for women at high risk for breast cancer from patients and physicians.

Secondary Outcome Measures

Full Information

First Posted
June 29, 2006
Last Updated
June 4, 2012
Sponsor
Rhode Island Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00347568
Brief Title
BC-DAISY: A Breast Cancer Decision Aid System
Official Title
BC-DAISY: A Breast Cancer Decision Aid System
Study Type
Interventional

2. Study Status

Record Verification Date
June 2012
Overall Recruitment Status
Completed
Study Start Date
July 2006 (undefined)
Primary Completion Date
September 2007 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rhode Island Hospital

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to develop a web-based decision aid to help women at high risk for breast cancer make informed breast cancer prevention choices. These choices include chemoprevention, surgery, genetic counseling, or regular screening in accordance with recommended guidelines.
Detailed Description
Decisions about breast cancer are complex and preference-based. Existing decision aids that help identify women eligible for tamoxifen based on their breast cancer risk, such as the Breast Cancer Risk Assessment Tool (BCRAT), were not designed to identify women's risks for side-effects, her preferences for outcomes affected by treatment, nor the net balance of benefits and risks. It is possible to predict the risks of side effects of treatments according to patient characteristics, using patient-specific models.Our goal is to develop a decision aid, TXplore, that rates the overall benefit:risk profiles of various breast cancer prevention strategies according to a woman's risks for breast cancer, side-effects, and preferences. Each user will receive a customized report card grading each available prevention option, using preference-weighted risk:benefit grades; users can also explore personalized feedback from the program. Our hypotheses are that this tool can improve the implementation of appropriate prevention strategies, promote risk reduction behavior, and improve PCP's ability to identify and counsel high risk women.We propose building on modeling techniques that link the benefits and risks of preventive strategies to patient characteristics and preferences. We now seek to conduct focus groups and usability tests on end-users to optimize the design of the prototype TXplore. The Specific Aims are: To optimize the design of TXplore by focus groups conducted among diverse high-risk women and PCPs to a) identify the domains driving decisions about prevention and explore the framing of questions comparing the relative importance of one domain to another, synthesizing this information as preference trade-off questions; and b) explore the framing of risk:benefit grades and personalized feedback. To assess the comprehensibility of preference trade-off questions by testing each question on a diverse sample of 50 high-risk women, revising and retesting. To assess the usability of TXplore for patients and PCPsThe successful completion of this project will produce a novel tool for counseling women about their individual benefits and risks of breast cancer prevention strategies. It will be the first tool of its kind to integrate individual patient risks and preferences into decision support.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
decision aids, high risk, breast cancer, breast cancer prevention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
195 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
TX-plore
Intervention Description
PI has terminated at institution and there is no one available to report.
Primary Outcome Measure Information:
Title
Usability feedback on new decision aid for women at high risk for breast cancer from patients and physicians.
Time Frame
9/01/06-8/31/07

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: between the ages of 21 - 75 at least one first degree relative with breast cancer or a Gail Model score signifying high risk female having had contact with a PCP (physician or nurse practitioner)within the last year being a patient at a participating clinic (for usability and pilot study) Exclusion Criteria: Inability to give informed, voluntary consent History of breast cancer or LCIS Language, vision, or reading difficulties, or non-English speaking Pregnancy women over 75 because of the lack of data guiding the impact of preventive treatments among this age group.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nananda Col, MD, MPP, MPH
Organizational Affiliation
Rhode Island Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rhode Island Hospital
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02903
Country
United States

12. IPD Sharing Statement

Learn more about this trial

BC-DAISY: A Breast Cancer Decision Aid System

We'll reach out to this number within 24 hrs